Psoriatic arthritis therapy ‘Guselkumab’ acquires approval in Korea

Published: 2018-04-18 18:29:55

Updated: 2018-04-18 18:29:55

‘Guselkumab(product name: Tremfya Prefilled Syringe Inj),’ a Janssen’s psoriasis & arthritis therapy, acquired approval in Korea.

The Ministry of Food and Drug Safety(MFDS) decided new drug approval on ‘Tremfya Prefilled Syringe Inj(generic name: guselkumab),’ a Janssen Korea’s psoriasis & arthritis therapy, on 12 April.

‘Tremfya Prefilled Syringe Inj’ is a gene recombinant therapy which is p...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.